Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

References for PMC Articles for PubMed (Select 19480695)

1.

Tailoring to RB: tumour suppressor status and therapeutic response.

Knudsen ES, Knudsen KE.

Nat Rev Cancer. 2008 Sep;8(9):714-24. doi: 10.1038/nrc2401.

2.

The cancer chemopreventive actions of phytochemicals derived from glucosinolates.

Hayes JD, Kelleher MO, Eggleston IM.

Eur J Nutr. 2008 May;47 Suppl 2:73-88. doi: 10.1007/s00394-008-2009-8. Review.

PMID:
18458837
3.

Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals.

Howells LM, Moiseeva EP, Neal CP, Foreman BE, Andreadi CK, Sun YY, Hudson EA, Manson MM.

Acta Pharmacol Sin. 2007 Sep;28(9):1274-304. Review.

4.

Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis.

Higdon JV, Delage B, Williams DE, Dashwood RH.

Pharmacol Res. 2007 Mar;55(3):224-36. Epub 2007 Jan 25. Review.

5.

Activation of caspase-8 contributes to 3,3'-Diindolylmethane-induced apoptosis in colon cancer cells.

Kim EJ, Park SY, Shin HK, Kwon DY, Surh YJ, Park JH.

J Nutr. 2007 Jan;137(1):31-6.

6.

Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane.

Reed GA, Arneson DW, Putnam WC, Smith HJ, Gray JC, Sullivan DK, Mayo MS, Crowell JA, Hurwitz A.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2477-81.

7.

The role of cell cycle regulatory proteins in the pathogenesis of melanoma.

Li W, Sanki A, Karim RZ, Thompson JF, Soon Lee C, Zhuang L, McCarthy SW, Scolyer RA.

Pathology. 2006 Aug;38(4):287-301.

PMID:
16916716
8.

Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin.

Lim do Y, Jeong Y, Tyner AL, Park JH.

Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G66-75. Epub 2006 Aug 10.

9.

Targeting the cell cycle: a new approach to cancer therapy.

Schwartz GK, Shah MA.

J Clin Oncol. 2005 Dec 20;23(36):9408-21. Review.

PMID:
16361640
10.

Indole-3-carbinol inhibits the growth of human colon carcinoma cells but enhances the tumor multiplicity and volume of azoxymethane-induced rat colon carcinogenesis.

Suzui M, Inamine M, Kaneshiro T, Morioka T, Yoshimi N, Suzuki R, Kohno H, Tanaka T.

Int J Oncol. 2005 Nov;27(5):1391-9.

PMID:
16211236
11.
12.

Molecular targets and anticancer potential of indole-3-carbinol and its derivatives.

Aggarwal BB, Ichikawa H.

Cell Cycle. 2005 Sep;4(9):1201-15. Epub 2005 Sep 6. Review.

13.

Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1.

Lim DY, Tyner AL, Park JB, Lee JY, Choi YH, Park JH.

J Cell Physiol. 2005 Oct;205(1):107-13.

PMID:
15880444
15.

3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice.

Chang X, Tou JC, Hong C, Kim HA, Riby JE, Firestone GL, Bjeldanes LF.

Carcinogenesis. 2005 Apr;26(4):771-8. Epub 2005 Jan 20.

16.

Indole-3-carbinol and prostate cancer.

Sarkar FH, Li Y.

J Nutr. 2004 Dec;134(12 Suppl):3493S-3498S. Review.

17.

Therapeutic activity of 3,3'-diindolylmethane on prostate cancer in an in vivo model.

Nachshon-Kedmi M, Fares FA, Yannai S.

Prostate. 2004 Oct 1;61(2):153-60.

PMID:
15305338
18.

Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice.

Anderton MJ, Manson MM, Verschoyle RD, Gescher A, Lamb JH, Farmer PB, Steward WP, Williams ML.

Clin Cancer Res. 2004 Aug 1;10(15):5233-41.

19.

A critical review of the bioavailability of glucosinolates and related compounds.

Holst B, Williamson G.

Nat Prod Rep. 2004 Jun;21(3):425-47. Epub 2004 May 12. Review.

PMID:
15162227
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk